MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
Peri-operative Pembrolizumab + Neoadjuvant Chemotherapy vs. Placebo + Neoadjuvant Chemotherapy for Cis-Eligible Muscle Invasive Bladder Cancer
3Phase III in Spain, 2Phase II, 1Phase I